Aura Biosciences

So much innovation! Are you up to date? We have it all covered at #CTS2025! Make sure to catch these two sessions with the world-renowned faculty on novel molecules in clinical development during #CTS2025 on June 21st, 2025! 1. Clinical Trials Investigating Therapies with Novel Mechanisms of Action #1 Moderator: Sophie Bakri Panelists: Ramanath Bhandari & Christopher D Riemann, MD OLN324: A Clinical-stage, Small-format, Higher-potency, High Molar Dose Bispecific VEGF/Ang-2 Inhibitor by Margaret Chang THN391 – A Novel Fibrin Targeting Antibody in Phase 1b for the Treatment of DME by Diana Do ANXV for the Treatment of RVO: A Potential Disease Modifying MOA by Michael Singer RO-104 Program Update and FIH Trial Design by Ramanath Bhandari Efficacy and Safety of Privosegtor in Neuroprotection: Results from a Multicenter, Randomized, Double Blinded Study (ACUITY) By Arshad M. Khanani Wnt Mediated Retinal Vascular Repair and Regeneration 2.0 by Craig Parker Long-Lasting Vision: Anchored Bi-functional Anti-VEGFs by David Boyer, MD 2. Clinical Trials Investigating Therapies with Novel Mechanisms of Action #2 Moderator: Avni Finn Panelists: Thomas Aaberg Jr & Tarek Hassan Optimizing the IVT Experience for Patients and Providers: Update on Current and Future Trials for Chloroprocaine Jeremiah Brown From the Eye to the Bladder and Beyond - Viral Drug Conjugates as a Platform for Solid Tumor Treatment by J. Jill Hopkins, MD Bel-sar - a New Treatment Paradigm in Choroidal Melanoma: Update on the Global Phase 3 CoMpass Trial by Jennifer Lim Pooled Outcomes from Three Randomized Studies Investigating Revakinagene Taroretcel-lwey for MacTel by Thomas Aaberg Jr Zifibancimig in Port Delivery Platform: The Future of Ang-2 Inhibition via Continuous Delivery by Giulio Barteselli, MD Phase 1 Study Design and Mechanism of Action of FLQ-101 for Prevention of ROP Darius M. Moshfeghi See you in Vegas on June 21st, 2025! Arshad M. Khanani Peter Kaiser Jeff Heier SriniVas Sadda Frank G. Holz Anat Loewenstein David Boyer, MD Diana Do Sophie Bakri Patricio Schlottmann #clinicaltrials #novel #CTS2025 #lasvegas

I am honored to join the stellar team at Aura Biosciences as Chief Financial and Business Officer. Aura's unique platform and approach position the Company with the opportunity to deliver first-in-disease therapeutic interventions across multiple cancer indications given its highly encouraging efficacy and safety/tolerability data. #aurabiosciences

In this weeks Biotech Leader Spotlight Series we're recognizing J. Jill Hopkins, MD, Chief Medical Officer at Aura Biosciences! Check out her interview to learn more about her impressive career in ophthalmology drug development: Jill is the Chief Medical Officer and President of Research & Development at Aura Biosciences. Before joining Aura, Jill served as Senior Vice President, Global Head of #Ophthalmology and Exploratory Development at Novartis, and Chief Executive Officer of Gyroscope Therapeutics, a Novartis company, where she was responsible for the global #ophthalmic pipeline and portfolio of medicines, gene therapy, devices and digital solutions to impact eye disease and reduce visual impairment globally. Previously, Dr. Hopkins spent over a decade at Roche-Genentech in roles of increasing responsibility, most recently as Global Head of Ophthalmology Personalized Health Care. Before Roche-Genentech, she spent over 20 years in clinical #retinal research and academic practice at the University of Toronto, University of Southern California, and Retina-Vitreous Associates Medical Group. Jill brings over 30 years of cross-sector experience in ophthalmology, spanning #clinical care, academia, education, industry, advocacy, and innovation. Dr. Hopkins received her M.D. from McMaster University and completed her Ophthalmology residency at the University of Toronto. She has completed fellowships in Retinal Disease from Moorfields Eye Hospital, London and in Visual Electrophysiology from the Universities of Toronto and Ottawa. Dr. Hopkins is board certified in Ophthalmology from the American Board of Ophthalmology and the Royal College of Physicians and Surgeons of Canada. Find more Biotech Leader Spotlights on www.partnology.com ! #biotech #biopharma #womeninbio #femaleleaders #drugdevelopment